Earnings Outlook For Plus Therapeutics







0.00% Post

Plus Therapeutics (NASDAQ:PSTV) is set to give its latest quarterly earnings report on Tuesday, 2023-10-31. Here's what investors need to know before the announcement.

Analysts estimate that Plus Therapeutics will report an earnings per share (EPS) of $-1.12.

Plus Therapeutics bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Past Earnings Performance

Last quarter the company beat EPS by $1.32, which was followed by a 2.8% drop in the share price the next day.

Here's a look at Plus Therapeutics's past performance and the resulting price change:

Quarter Q2 2023 Q1 2023 Q4 2022 Q3 2022
EPS Estimate -1.91 -1.95 -1.8 -3.30
EPS Actual -0.59 -2.10 -2.4 -2.85
Price Change % -2.8% -13.98% -6.89% -3.13%

eps graph

Stock Performance

Shares of Plus Therapeutics were trading at $1.07 as of October 27. Over the last 52-week period, shares are down 84.4%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.

To track all earnings releases for Plus Therapeutics visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Every question you ask will be answered
Scan the QR code to contact us
Also you can contact us via